Inclusion body myositis Steven A. Greenberg
|
|
- Jocelin Chandler
- 6 years ago
- Views:
Transcription
1 Inclusion body myositis Steven A. Greenberg Division of Neuromuscular Disease, Department of Neurology, Brigham and Women s Hospital, and Children s Hospital Informatics Program, Harvard Medical School, Boston, Massachusetts, USA Correspondence to Steven A. Greenberg, MD, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA Tel: ; sagreenberg@partners.org Current Opinion in Rheumatology 2011, 23: Purpose of review Sporadic inclusion body myositis (sibm) is a poorly understood immune and degenerative disease of skeletal muscle. Here, current opinion of the nature of this disease is summarized. Recent findings Recent findings for sibm include further characterization of muscle involvement through magnetic resonance imaging, the role of muscle as a host for immune cells, progress in the role of extranuclear TDP-43 in causing cellular injury, and the discovery of a new sibm autoantibody. Summary sibm understanding continues to advance, with progress regarding the mechanism of this disease. Keyword inclusion body myositis Curr Opin Rheumatol 23: ß 2011 Wolters Kluwer Health Lippincott Williams & Wilkins Introduction Sporadic inclusion body myositis (sibm) is a slowly progressive degenerative and inflammatory disorder of skeletal muscle of unknown cause beginning in middle or later life. Selective involvement of specific muscles, including finger flexors and quadriceps, together with certain degenerative and immune muscle histopathological changes and refractoriness to treatment are distinctive features of this syndrome. Epidemiology sibm is the most common muscle disease of aging, generally affecting individuals over the age of 50. A number of recent reviews are available [1 6]. sibm prevalence estimates vary widely across different ethnic populations. Per million estimates include 1.0 in Turkey, 4.7 in the Netherlands [7], 10.7 in Connecticut USA [8], 14.9 in western Australia [9], and 71 in Olmsted County USA [10]. Age 50 or greater prevalence estimates are approximately three-fold higher [11]. sibm is considered to be rare among Asians and African Americans [11]. Clinical features sibm is a slowly progressive muscle disease with symptoms generally due to a specific pattern of muscle involvement (see for example [12,13]). Involvement of the quadriceps muscle, resulting in difficulty walking and knee buckling, and finger flexors, resulting in grip weakness, are distinctive features (Fig. 1). Finger flexor weakness is commonly worse on the nondominant side [14,15]. Ankle dorsiflexion weakness ( footdrop ) is common, and dysphagia may occur but is typically not severe. Delayed diagnosis (average time 5.2 years) [15] and misdiagnosis [11] are common observations. Overreliance on muscle biopsy features relative to clinical features contributes to misdiagnosis, with failure to recognize weakness of flexor digitorum profundi (flexing the finger tips) or flexor digitorum superficialis (flexing fingers at their proximal interphalangeal joints) is likely the most common reason for misdiagnosis. MRI is helpful in delineating specific patterns of muscle involvement [16,17]. Pathology The muscle pathology of sibm typically demonstrates extensive endomysial inflammation, with inflammatory cells surrounding myofibers, as well as less specific myopathic features (for example, fibrosis, variation in myofiber size, and atrophic fibers). Although invasion of nonnecrotic myofibers by inflammatory cells has been frequently emphasized, the surrounding of myofibers by these cells without invasion is far more common. Nodular collections are frequently present and often displace myofibers [18]. Rimmed vacuoles, more commonly visible on Gomori trichrome stains than hematoxylin and eosin (H&E) stains, are variably present in approximately 1 6% of myofibers [19]. The rimmed vacuoles seen on frozen sections are in part artifactual, as these empty spaces contain cytomembranous and nuclear material visible in glutaraldehyde-fixed toluidine stained thin sections that better preserve muscle morphology (Fig. 2). Masses of tubulofilaments visible by electron microscopy are often within nuclei or ß 2011 Wolters Kluwer Health Lippincott Williams & Wilkins DOI: /BOR.0b013e32834b53cc
2 2 Myositis and myopathies Figure 1 Clinical features Key points Inclusion body myositis (IBM) is a disease with much opportunity for further research and understanding. IBM is a highly atrophying disease and the mechanism of this atrophy is unknown. An IBM autoantibody was recently reported. presence of the cytotoxic T-cell molecules perforin, granzyme A, and granulysin [26]. These models propose that the common final pathway by which the immune system injures IBM muscle is cytotoxic T-cell invasion of myofibers. However, it is noteworthy that the vast (a) Finger flexor weakness in sporadic inclusion body myositis (sibm). Patient attempting to close both hands. (b) Quadriceps atrophy visible with T1 axial MRI. Severe involvement of vastus lateralis and vastus medialis (white arrows) with relative preservation of rectus femoris (black arrow) and the posterior thigh is characteristic of sibm. Figure 2 Sporadic inclusion body myositis myonuclear pathology in clumps suggestive of former nuclei devoid of nuclear membrane (Fig. 2). Diagnostic criteria sibm diagnosis depends foremost on the clinical pattern of weakness, supported by laboratory features (serum creatine kinase that is not too elevated) and pathological features. Among patients with difficulty distinguishing sibm from polymyositis, an sibm pattern of weakness (clinical sibm) is predictive of treatment refractoriness even in the absence of biopsy-evident rimmed vacuoles (biopsy polymyositis) [20]. For research purposes, the European Neuromuscular Centre (ENMC) diagnostic criteria [7] recognize this important point, allowing a diagnosis of probable sibm if typical clinical features are present but rimmed vacuoles absent. Immunology: genomic studies, mechanisms, and autoantibody discovery Immune injury of IBM myofibers has traditionally been viewed as due to cytotoxic T cells. Recent studies have demonstrated expanded roles for other arms of the immune system, including myeloid dendritic cells (mdcs) [21], B cells [18,22 24], and a newly discovered IBM autoantibody [25 ]. T cells A role of cytotoxic T cells in IBM myofiber injury has long been recognized and emphasized. Models of such injury are based on observations of the types and locations of T cells present in muscle, the nature of the T-cell antigen receptor present on these cells, and the (a, b) Rimmed vacuoles typically are lined with nuclear membrane proteins, such as emerin (shown here) and lamin A/C. (c) Vacuoles seen on glutaraldehyde-fixed toluidine blue stained thin sections show vacuoles are not empty spaces but contained packed structures including degrading nuclei and membranous material. (d) Electron micrograph showing a mass of tubulofilaments within a nucleus. (e-1, e-2) TDP43 sarcoplasmic deposits in a myofiber whose nuclei are devoid of TDP43 (white arrowheads). Panels a and d reproduced with permission from [19].
3 Inclusion body myositis Greenberg 3 majority of immune system cells in IBM muscle biopsy cross-sections appear to surround but not invade myofibers (Fig. 3a). These immune cells may be injuring myofibers through secreted molecules, not visible to the pathologist by microscopy. Very little study of the soluble immune protein compartment of IBM muscle has been performed. B cells B cells as defined by the surface markers CD19 and CD20 were long thought to be sparse or absent from IBM muscle, based on pivotal immunohistochemical studies performed in 1984 [27]. Surprisingly, microarray studies published in 2002 [22] showed an abundance of immunoglobulin transcripts in IBM muscle and led to the recognition in 2005 that plasma cells (CD138 þ differentiated B cells) are transcriptionally active, producing and secreting immunoglobulins within IBM muscle [23], and in 2007 that these plasma cells are antigen directed and clonally expanded [24]. Figure 3 Sporadic inclusion body myositis immunology Inclusion body myositis muscle has become an immune cell host Recent evidence indicates that IBM muscle has become an immune cell host, a place where B cells mature into plasma cells and mdcs activate T-helper cells (Fig. 3c) [18]. Nodular collections of immune cells (Fig. 3b) studied by serial sections and laser capture microdissection demonstrate the presence of plasma cells producing immunoglobulins with the same antigen specificity, therefore derived from a common precursor, developing in an environment rich in T-helper cells and the cytokine B-cell activating factor (BAFF). These nodular collections are unlike typical germinal center B-cell follicles recognized in other autoimmune disease tissue sites. Skeletal muscle is probably not well suited to function as both a force-generating contractile tissue and a lymphoid tissue supporting an environment for immune-cell interaction and maturation. The presence of this activity in IBM-diseased tissue provides a rationale for targeting molecules involving mdc/t-cell and T-cell/B-cell interactions in therapeutic trials of inflammatory myopathies. Anti-IBM-43: an inclusion body myositis autoantibody Recognition that a B-cell-specific response was present in IBM muscle and characterization of this response suggested that a search for circulating IBM autoantibodies might be fruitful. Since 1980 [28,29], autoantibodies have been recognized associated with polymyositis and dermatomyositis (reviewed in [30,31]) but no IBM autoantibody has been identified. In 2011, an autoantibody against a 43 kda muscle protein (anti-ibm-43) was identified [25 ]. Plasma samples from 50 patients with myositis (25 with IBM, 10 with dermatomyositis, 10 with polymyositis, and five with myasthenia gravis) and 15 normal samples were examined by western blot for their binding to human muscle proteins from biopsy specimens. An autoantibody to an approximately 43 kda human muscle protein was present in 52% (13/ 25) of the IBM samples and 0% (0/40) of all other samples (Fig. 4). For patients with myositis, this antibody, thus, had 52% sensitivity and 100% specificity for IBM. The identity of the 43 kda protein has not been established. (a) Extensive cellular infiltrate displacing and surrounding myofibers without any invasion into myofibers. Numerous abnormally small myofibers are present near and inside this infiltrate, suggesting secreted products of these immune cells are injuring these myofibers. (b) Nodular collection of immune cells, typed on serial sections. This nodule contains T cells, myeloid dendritic cells (BDCA1), B cells (CD19), and plasma cells (CD138) around its periphery, suggesting that plasma cells are maturing from B cells in this nodule. (c) Myeloid dendritic cells from panel b enlarged and shown in their dendritic morphology, apparently making close contact with T cells, perhaps presenting antigen to them. Panel b reproduced with permission from [18]. Nuclear degeneration: from rimmed vacuoles to TDP-43 Myonuclear degeneration was emphasized as a prominent part of IBM pathology in the earliest studies by Chou in 1967 [32] and by Carpenter, Karpati, and coworkers in 1978 [33], and [34 36]. These investigators formulated a hypothesis that rimmed vacuoles, a pathological feature that distinguishes IBM from other inflammatory myopathies on H&E and trichrome stained muscle sections, derived from the
4 4 Myositis and myopathies Figure 4 A new inclusion body myositis autoantibody anti-ibm-43 Western blot of myositis plasma samples [eight sporadic inclusion body myositis (sibm) samples, five dermatomyositis (DM), and five polymyositis (PM) samples] against human muscle biopsy lysates shows reactivity of sibm plasma exclusively to an approximately 43 kda muscle protein of unknown identity. Reproduced with permission from [25 ]. breakdown of myonuclei. This hypothesis was neglected in the medical literature between 1996 and There are at least 31 review papers on IBM written during this period [37]; none mentioned the existence of these data regarding myonuclear degeneration, the theory advocated by Chou, Carpenter, and Karpati, or its implications. A resurgence of interest in IBM myonuclear degeneration has developed since recognition in 2006 that the vast majority of rimmed vacuoles are lined with nuclear membrane proteins, suggesting they derive from myonuclear breakdown (Fig. 2) [19,37]. One study found that 73% of H&E-defined rimmed vacuoles are lined with the nuclear membrane protein emerin. Recent studies continue to observe myonuclear degeneration [38]. The tubulofilaments that have been long recognized in IBM are frequently intranuclear (Fig. 2). The recent discovery of the nucleic acid-binding protein TDP-43 in IBM nonnuclear sarcoplasm by four independent laboratories [39 42] is a major advance in this longignored theory. TDP-43 is a predominantly nuclear heterogeneous nuclear ribonucleoprotein (hnrnp) that undergoes nucleocytoplasmic shuttling and associates with translation machinery in the cytoplasm. TDP-43 has two RNA-recognition motifs (RRMs) capable of binding both DNA and RNA [43]. In IBM, 23% of myofibers contain nonnuclear sarcoplasmic TDP-43 accumulations; these fibers contain nuclear TDP-43 in only 12% of their nuclei, compared with TDP-43 s presence in 99% of normal muscle myonuclei (Fig. 2) [40]. TDP-43 has, thus, redistributed from nuclei to sarcoplasm in a large percentage of IBM myofibers. In western blot studies, abnormal TDP-43 degradation products are unique to sibm among other inflammatory myopathy samples. TDP-43 sarcoplasmic accumulation is a highly sensitive and specific biomarker for IBM; the presence of more than 1% of affected myofibers was 91% sensitive and 100% specific to sibm among 50 samples with inflammatory myopathies [40]. The consequences of TDP-43 redistribution have been unknown until recently. It is now clear that aberrant extranuclear accumulation of TDP-43 is toxic to cells, and that this toxicity depends on the TDP-43 nucleic acid-binding domain [44 ]. In a Drosophila model, targeting TDP-43 to cytoplasm by mutating its nuclear localization signal resulted in cellular cytotoxicity that was rescued after additionally mutating TDP-43 s RRM nucleic acid-binding domain. These studies suggest that accumulation of extranuclear TDP-43 is toxic through its binding to RNA. Other theories Many theories of pathogenesis of sibm have been proposed over the four decades since its pathological delineation [32]. A potential viral etiology has repeatedly intrigued researchers, bolstered by the existence of HIV and human T-lymphotropic virus type I (HTLV-1)- associated sibm [45]. The presence of mitochondrial abnormalities has been studied [46,47]. Toxicity theories of various molecules have dominated the field for two decades [48], with one such molecule forming the basis for at least 13 animal model publications (reviewed in [2]). This literature has been reviewed from the perspective of citation and belief [49]. Conclusion sibm remains a poorly understood inflammatory, atrophying muscle disease for which there is a major need for effective treatment. Of the inflammatory myopathies, it has the most intense and refined adaptive immune system response, yet remains refractory to all immune treatments reported tried to date. There is currently no understanding as to the cause and mechanism of the myonuclear and sarcoplasmic degeneration resulting in loss of myofibers and disability in patients with sibm. Acknowledgements The author thanks the Muscular Dystrophy Association for inclusion body myositis research support through grants MDA and MDA4353. Conflicts of interest There are no conflicts of interest.
5 Inclusion body myositis Greenberg 5 References and recommended reading Papers of particular interest, published within the annual period of review, have been highlighted as: of special interest of outstanding interest Additional references related to this topic can also be found in the Current World Literature section in this issue (pp ). 1 Solorzano GE, Phillips LH 2nd. Inclusion body myositis: diagnosis, pathogenesis, and treatment options. Rheum Dis Clin North Am 2011; 37: ; v. 2 Greenberg SA. Theories of the pathogenesis of inclusion body myositis. Curr Rheumatol Rep 2010; 12: Amato AA, Barohn RJ. Inclusion body myositis: old and new concepts. J Neurol Neurosurg Psychiatry 2009; 80: Karpati G, O Ferrall EK. Sporadic inclusion body myositis: pathogenic considerations. Ann Neurol 2009; 65: Garlepp MJ, Mastaglia FL. Inclusion body myositis: new insights into pathogenesis. Curr Opin Rheumatol 2008; 20: Needham M, Mastaglia FL. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 2007; 6: Badrising UA, Maat-Schieman M, van Duinen SG, et al. Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 2000; 55: Felice KJ, North WA. Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period. Medicine (Baltimore) 2001; 80: Needham M, Corbett A, Day T, et al. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis. J Clin Neurosci 2008; 15: Wilson FC, Ytterberg SR, St Sauver JL, Reed AM. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. J Rheumatol 2008; 35: Mastaglia FL. Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC. Acta Myol 2009; 28: Phillips BA, CalaLA, Thickbroom GW, et al. Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study. Muscle Nerve 2001; 24: Badrising UA, Maat-Schieman ML, van Houwelingen JC, et al. Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients. J Neurol 2005; 252: Felice KJ, Relva GM, Conway SR. Further observations on forearm flexor weakness in inclusion body myositis. Muscle Nerve 1998; 21: Needham M, James I, Corbett A, et al. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry 2008; 79: Cox FM, Reijnierse M, van Rijswijk CS, et al. Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis. Rheumatology (Oxford) 2011; 50: A study of muscle selectivity as determined by MRI. 17 Dion E, Cherin P, Payan C, et al. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol 2002; 29: Salajegheh M, Pinkus JL, Amato AA, et al. Permissive environment for B cell maturation in myositis muscle in the absence of B cell follicles. Muscle Nerve 2010; 42: Greenberg SA, Pinkus JL, Amato AA. Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis. Muscle Nerve 2006; 34: Chahin N, Engel AG. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 2008; 70: Greenberg SA, Pinkus GS, Amato AA, Pinkus JL. Myeloid dendritic cells in inclusion-body myositis and polymyositis. Muscle Nerve 2007; 35: Greenberg SA, Sanoudou D, Haslett JN, et al. Molecular profiles of inflammatory myopathies. Neurology 2002; 59: Greenberg SA, Bradshaw EM, Pinkus JL, et al. Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 2005; 65: Bradshaw EM, Orihuela A, McArdel SL, et al. A local antigen-driven humoral response is present in the inflammatory myopathies. J Immunol 2007; 178: Salajegheh M, Lam T, Greenberg SA. Autoantibodies against a 43 kda muscle protein in inclusion body myositis. PLoS One 2011; 6:e Identification of an IBM autoantibody is reported. 26 Greenberg SA. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 2007; 69: Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984; 16: Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum 1980; 23: Nishikai M, Reichlin M. Purification and characterization of a nuclear nonhistone basic protein (Mi-1) which reacts with antiimmunoglobulin sera and the sera of patients with dermatomyositis. Mol Immunol 1980; 17: Hengstman GJ, van Engelen BG, van Venrooij WJ. Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol 2004; 16: Mammen AL. Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 2010; 1184: Chou SM. Myxovirus-like structures in a case of human chronic polymyositis. Science 1967; 158: Carpenter S, Karpati G, Heller I, Eisen A. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 1978; 28: Karpati G, Carpenter S. Pathology of the inflammatory myopathies. Baillieres Clin Neurol 1993; 2: Nalbantoglu J, Karpati G, Carpenter S. Conspicuous accumulation of a singlestranded DNA binding protein in skeletal muscle fibers in inclusion body myositis. Am J Pathol 1994; 144: Carpenter S. Inclusion body myositis, a review. J Neuropathol Exp Neurol 1996; 55: Greenberg SA. Inflammatory myopathies: disease mechanisms. Curr Opin Neurol 2009; 22: Nishii M, Nakano S, Nakamura S, et al. Myonuclear breakdown in sporadic inclusion body myositis is accompanied by DNA double strand breaks. Neuromuscul Disord 2011; 21: Weihl CC, Temiz P, Miller SE, et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 2008; 79: Salajegheh M, Pinkus JL, Taylor JP, et al. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 2009; 40: Kusters B, van Hoeve BJ, Schelhaas HJ, et al. TDP-43 accumulation is common in myopathies with rimmed vacuoles. Acta Neuropathol 2009; 117: Olive M, Janue A, Moreno D, et al. TAR DNA-binding protein 43 accumulation in protein aggregate myopathies. J Neuropathol Exp Neurol 2009; 68: Kuo PH, Doudeva LG, Wang YT, et al. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res 2009; 37: Ritson GP, Custer SK, Freibaum BD, et al. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci 2010; 30: It reports cytotoxicity of extranuclear TDP-43 dependent on its nucleic acid-binding ability. 45 Cupler EJ, Leon-Monzon M, Miller J, et al. Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain 1996; 119: Rifai Z, Welle S, Kamp C, Thornton CA. Ragged red fibers in normal aging and inflammatory myopathy. Ann Neurol 1995; 37: Oldfors A, Moslemi AR, Jonasson L, et al. Mitochondrial abnormalities in inclusion-body myositis. Neurology 2006; 66 (2 Suppl 1):S49 S Askanas V, Engel WK. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-beta42 oligomers and phosphorylated tau. Presse Med 2011; 40 (4 Pt 2):e219 e Greenberg SA. How citation distortions create unfounded authority: analysis of a citation network. BMJ 2009; 339:b2680.
Pathogenesis and therapy of inclusion body myositis
REVIEW C URRENT OPINION Pathogenesis and therapy of inclusion body myositis Steven A. Greenberg Purpose of review Inclusion body myositis (IBM) is a poorly understood progressive muscle disease of middle
More informationGenetics of Inclusion Body Myositis
Genetics of Inclusion Body Myositis Thomas Lloyd, MD, PhD Associate Professor of Neurology and Neuroscience Co-director, Johns Hopkins Myositis Center Sporadic IBM (IBM) Age at onset usually > 50 Prevalence
More informationChapter 5 Inclusion Body Myositis
Chapter 5 Inclusion Body Myositis Lawrence J. Kagen Abstract Inclusion body myositis is an insidious, slowly progressive myopathy of middle-aged and older individuals. Because of these characteristics,
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/29855 holds various files of this Leiden University dissertation. Author: Cox, Fieke Maria Elisabeth Title: Inclusion body myositis. Clinical aspects Issue
More informationInclusion Body Myositis: Diagnosis, Pathogenesis, and Treatment Options
Inclusion Body Myositis: Diagnosis, Pathogenesis, and Treatment Options Guillermo E. Solorzano, MD*, Lawrence H. Phillips II, MD KEYWORDS Inclusion body myositis Pathogenesis Treatment Sporadic inclusion
More informationLong-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients
Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients C. Dobloug, R. Walle-Hansen, J.T. Gran, Ø. Molberg Section of Rheumatology,
More informationAn autoimmune perspective on neuromuscular diseases
An autoimmune perspective on neuromuscular diseases Colin Chalk MD,CM FRCPC Montreal General Hospital McGill University Schlomchik 2001 The proportion of neuromuscular patients who have an autoimmune cause
More informationINCLUSION BODY MYOSITIS. Bill Tillier Calgary, Alberta February, 2014.
INCLUSION BODY MYOSITIS. Bill Tillier Calgary, Alberta February, 2014. IBM classification. 2 Sporadic Inclusion Body Myositis (sibm) is classified as a type of muscle disease. Idiopathic inflammatory myositis
More informationEvaluation and construction of diagnostic criteria for inclusion body myositis
Evaluation and construction of diagnostic criteria for inclusion body myositis Thomas E. Lloyd, MD, PhD Andrew L. Mammen, MD, PhD Anthony A. Amato, MD Michael D. Weiss, MD Merrilee Needham, MBBS Steven
More informationCase 1: History of J.H. Outside Evaluation. Outside Labs. Question #1
Case 1: History of J.H. 64 yo man seen at UCSF 6-256 25-07. 9 months ago onset progressive weakness of arms and legs, with muscle atrophy in arms. 4 months ago red scaly rash on face, back of hands and
More informationPrognosis and prognostic factors in sporadic inclusion body myositis
Acta Neurol Scand 212: 125: 353 358 DOI: 1.1111/j.16-44.211.1584.x Ó 211 John Wiley & Sons A S ACTA NEUROLOGICA SCANDINAVICA Prognosis and prognostic factors in sporadic inclusion body myositis Lindberg
More informationDiagnostic value of markers of muscle degeneration in sporadic inclusion body myositis
Acta Myologica 2011; XXX: p. 103-108 Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis O. Dubourg 1, J. Wanschitz 2, T. Maisonobe 1, A. Béhin 3, Y. Allenbach 4, S.
More informationKumaraswamy Sivakumar, Christina Semino-Mora and Marinos C. Dalakas
braini0310 Brain (1997), 120, 653 661 An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis Studies in three families
More informationTMA San Diego September 7, 2017
Myositis 101: Clinical Features, Diagnosis and Management Namita Goyal, MD Associate Professor of Neurology Director, Neuromuscular Medicine Fellowship Director, Neuromuscular Diagnostic Laboratory Associate
More informationDEMOGRAPHIC AND CLINICAL FEATURES OF INCLUSION BODY MYOSITIS IN NORTH AMERICA
DEMOGRAPHIC AND CLINICAL FEATURES OF INCLUSION BODY MYOSITIS IN NORTH AMERICA A. DAVID PALTIEL, PhD, 1,2 EINAR INGVARSSON, MBA, 2 DONALD K. K. LEE, PhD, 2 RICHARD L. LEFF, MD, 3 RICHARD J. NOWAK, MD, 4
More informationIII./10.4. Diagnosis. Introduction. A.) Laboratory tests. Laboratory tests, electrophysiology, muscle biopsy, genetic testing, imaging techniques
III./10.4. Diagnosis Laboratory tests, electrophysiology, muscle biopsy, genetic testing, imaging techniques After studying this chapter, you will become familiar with the most commonly used diagnostic
More informationIdiopathic inflammatory myopathies excluding inclusion body myositis
Idiopathic inflammatory myopathies excluding inclusion body myositis Marianne de Visser, Dept. of Neurology, Academic Medical Centre, Amsterdam, The Netherlands The idiopathic inflammatory myopathies (IIMs),
More informationBcl-2, Bcl-x, and Bax Expression by Immunohistochemistry in Inclusion Body Myositis A Study of 27 Cases
Bcl-2, Bcl-x, and Bax Expression by Immunohistochemistry in Inclusion Body Myositis A Study of 27 Cases Richard A. Prayson, MD; Albert C. Yu, MD Context. Bcl-2, Bcl-x, and Bax are among the variety of
More informationAutoantibodies in the Idiopathic Inflammatory Myopathies
Autoantibodies in the Idiopathic Inflammatory Myopathies Steven R. Ytterberg, M.D. Division of Rheumatology Mayo Clinic Rochester, MN The Myositis Association Annual Conference St. Louis, MO Sept. 25,
More informationAmyloid neuropathy: (A) scattered Congo Red positive material in endoneurium displays apple green birefringence under polarized light.
Cơ vân Cơ vân Cơ vân (cắt dọc) Amyloid neuropathy: (A) scattered Congo Red positive material in endoneurium displays apple green birefringence under polarized light. (A, Congo Red). Amyloid neuropathy:
More informationMagnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle
RHEUMATOLOGY Rheumatology 2015;54:1017 1024 doi:10.1093/rheumatology/keu422 Advance Access publication 21 November 2014 Original article Magnetic resonance imaging changes of thigh muscles in myopathy
More informationImmunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells
Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells Andrew H. Lichtman, M.D. Ph.D. Department of Pathology Brigham and Women s Hospital and Harvard
More informationInclusion body myositis
Pathology Feature William R. Hart, M.D. Section Editor Inclusion body myositis A possible chronic persistent muscle infection mumps virus 1 Samuel M. Chou, M.D., Ph.D. Inclusion body myositis was diagnosed
More informationInclusion body myositis: clinical review and current practice
& ur- Inclusion body myositis: clinical review and current practice Practice points Inclusion body myositis (IBM) is the commonest acquired myopathy in patients aged over 50 years with males more frequently
More informationThe Role of Electron Microscopy in the Assessment of Dermatomyositis: A Retrospective Pilot Study on Skeletal Muscle Biopsies
British Journal of Medicine & Medical Research 3(4): 962-970, 2013 SCIENCEDOMAIN international www.sciencedomain.org The Role of Electron Microscopy in the Assessment of : A Retrospective Pilot Study on
More informationInclusion body myositis clinical features, diagnosis and management
Inclusion body myositis clinical features, diagnosis and management Marianne de Visser Academic Medical Center Dept. of Neurology Amsterdam, The Netherlands Inclusion body myositis Most frequent myopathy
More informationInclusion body myositis: an underdiagnosed
Department of Immunology, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom N D Hopkinson R J Powell Department of Histopathology, University Hospital, Queen's Medical Centre,
More informationThis month, we are very pleased to introduce some new tests for Scleroderma as well as some test changes to our existing scleroderma tests/panels.
February 20, 2017 Client Letter Test Update February 2017 Dear Colleague: This month, we are very pleased to introduce some new tests for Scleroderma as well as some test changes to our existing scleroderma
More informationElectron microscopy in the investigation and diagnosis of muscle disease
Electron microscopy in the investigation and diagnosis of muscle disease Roy Weller Clinical Neurosciences University of Southampton School of Medicine Normal Muscle Normal Muscle The Sarcomere The names
More informationOriginal Article Pathological findings in sporadic inclusion body myositis and GNE myopathy
Int J Clin Exp Pathol 2018;11(5):2907-2911 www.ijcep.com /ISSN:1936-2625/IJCEP0064777 Original Article Pathological findings in sporadic inclusion body myositis and GNE myopathy Yutong Zhang 1, Chuanqiang
More informationMHC class I MHC class II Structure of MHC antigens:
MHC class I MHC class II Structure of MHC antigens: MHC class I antigens consist of a transmembrane heavy chain (α chain) that is non-covalently associated with β2- microglobulin. Membrane proximal domain
More informationSMA IS A SEVERE NEUROLOGICAL DISORDER [1]
SMA OVERVIEW SMA IS A SEVERE NEUROLOGICAL DISORDER [1] Autosomal recessive genetic inheritance 1 in 50 people (approximately 6 million Americans) are carriers [2] 1 in 6,000 to 1 in 10,000 children born
More informationEDUCATIONAL COMMENTARY MORPHOLOGIC ABNORMALITIES IN LEUKOCYTES
EDUCATIONAL COMMENTARY MORPHOLOGIC ABNORMALITIES IN LEUKOCYTES Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More informationThe spectrum of elderly myopathies in an Asian population
Neurology Asia 2013; 18(2) : 177 181 The spectrum of elderly myopathies in an Asian population Shereen Ng, *Kum-Thong Wong FRCPath MD, Khean-Jin Goh FRCP Division of Neurology, Department of Medicine and
More informationThe many faces of myositis. Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands
The many faces of myositis Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands Outline of the presentation Classification Diagnosis Therapy Prognosis Diagnostic criteria
More informationIBM: sporadic vs. hereditary There is no true hereditary IBM. New research developments for IBM. Classification of hereditary IBM outdated term!
New research developments for IBM IBM: sporadic vs. hereditary There is no true hereditary IBM IBM Distal Myopathy E.g. Myofibrillar Myopathy Jens Schmidt, MD, FAAN, FEAN Dept. of Neurology University
More informationMuscular Dystrophy. Biol 405 Molecular Medicine
Muscular Dystrophy Biol 405 Molecular Medicine Duchenne muscular dystrophy Duchenne muscular dystrophy is a neuromuscular disease that occurs in ~ 1/3,500 male births. The disease causes developmental
More informationDiseases of Muscle and Neuromuscular Junction
Diseases of Muscle and Neuromuscular Junction Diseases of Muscle and Neuromuscular Junction Neuromuscular Junction Muscle Myastenia Gravis Eaton-Lambert Syndrome Toxic Infllammatory Denervation Atrophy
More informationOverview of Diagnostic Autoantibodies in Inflammatory Myopathy
Overview of Diagnostic Autoantibodies in Inflammatory Myopathy Minoru Satoh, M.D., Ph.D. Research Associate Professor of Medicine Division of Rheumatology and Clinical Immunology University of Florida
More information4/16/2018. Demystifying weakness: how to approach refractory myositis. Objectives. Disclosures. Off-label uses for medications will be discussed
Demystifying weakness: how to approach refractory myositis Jemima Albayda, MD Assistant Professor Johns Hopkins Myositis center Disclosures Off-label uses for medications will be discussed Objectives To
More informationMuscle Pathology Surgical Pathology Unknown Conference. November, 2008 Philip Boyer, M.D., Ph.D.
Muscle Pathology Surgical Pathology Unknown Conference November, 2008 Philip Boyer, M.D., Ph.D. Etiologic Approach to Differential Diagnosis Symptoms / Signs / Imaging / Biopsy / CSF Analysis Normal Abnormal
More informationGranulomatous Myositis Clinicopathologic Study of 12 Cases
Anatomic Pathology / GRANULOMATOUS MYOSITIS Granulomatous Myositis Clinicopathologic Study of 12 Cases Richard A. Pray son, MD Key Words: Granulomas; Granulomatous myositis; Myositis; Granulomatous inflammation
More informationImmunology - Lecture 2 Adaptive Immune System 1
Immunology - Lecture 2 Adaptive Immune System 1 Book chapters: Molecules of the Adaptive Immunity 6 Adaptive Cells and Organs 7 Generation of Immune Diversity Lymphocyte Antigen Receptors - 8 CD markers
More informationMedical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University
Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve
More informationRole of BAFF in B cell Biology and Autoimmunity
Role of BAFF in B cell Biology and Autoimmunity B cell development in health and disease: B-lymphocytes or B cells, and the antibodies they produce, are crucial mediators of humoral immunity, providing
More informationCELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.
!! www.clutchprep.com CONCEPT: OVERVIEW OF HOST DEFENSES The human body contains three lines of against infectious agents (pathogens) 1. Mechanical and chemical boundaries (part of the innate immune system)
More informationAntigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS
1 Antigen Presentation and T Lymphocyte Activation Abul K. Abbas UCSF FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T cell activation Costimulation, the B7:CD28 family
More informationTitle: Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy
Author's response to reviews Title: Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy Authors: Vered Raz (v.raz@lumc.nl)
More informationPattern of muscle involvement in inclusion body myositis: a sonographic study
Pattern of muscle involvement in inclusion body myositis: a sonographic study J. Albayda 1, L. Christopher-Stine 1, C.O. Bingham III 1, J.J. Paik 1, E. Tiniakou 1, S. Billings 2, O.M. Uy 2, P. Burlina
More informationHLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol
HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared
More informationEnzyme histochemistry of skeletal muscle
J. Neurol. Neurosurg. Psychiat., 1966, 29, 23 Enzyme histochemistry of skeletal muscle Part III Neurogenic muscular atrophies VICTOR DUBOWITZ From the Department of Child Health, University of Sheffield
More informationObjectives. Non-Traumatic Muscle Pathologies. Abnormal Muscle Signal Intensity. Inflammatory Myositis. Polymyostis / Dermatomyositis.
Non-Traumatic Muscle Pathologies Ali Naraghi Division of Musculoskeletal Radiology Joint Department of Medical Imaging University of Toronto Objectives Define the range of non-traumatic pathologies affecting
More informationDefensive mechanisms include :
Acquired Immunity Defensive mechanisms include : 1) Innate immunity (Natural or Non specific) 2) Acquired immunity (Adaptive or Specific) Cell-mediated immunity Humoral immunity Two mechanisms 1) Humoral
More informationmuscle biopsy How to do it
How to do it muscle biopsy Gillian Hall Department of Clinical Neurosciences, Western General Hospital, Edinburgh EH4 2XU. Email: ghall@skull.dcn.ed.ac.uk INTRODUCTION Good clinical evaluation remains
More informationT-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:
Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,
More informationT-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:
Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,
More informationAutoantibodies in Idiopathic Inflammatory Myopathies. Vidya Limaye Rheumatology Department Royal Adelaide Hospital
Autoantibodies in Idiopathic Inflammatory Myopathies Vidya Limaye Rheumatology Department Royal Adelaide Hospital Idiopathic Inflammatory Myopathies (IIM) Heterogeneous group of systemic autoimmune syndromes
More informationThe Lymphatic System and Body Defenses
PowerPoint Lecture Slide Presentation by Patty Bostwick-Taylor, Florence-Darlington Technical College The Lymphatic System and Body Defenses 12PART B Adaptive Defense System: Third Line of Defense Immune
More informationImmune system. Aims. Immune system. Lymphatic organs. Inflammation. Natural immune system. Adaptive immune system
Aims Immune system Lymphatic organs Inflammation Natural immune system Adaptive immune system Major histocompatibility complex (MHC) Disorders of the immune system 1 2 Immune system Lymphoid organs Immune
More information5/1/13. The proportion of thymus that produces T cells decreases with age. The cellular organization of the thymus
T cell precursors migrate from the bone marrow via the blood to the thymus to mature 1 2 The cellular organization of the thymus The proportion of thymus that produces T cells decreases with age 3 4 1
More informationAnesthesia recommendations for patients suffering from Welander distal myopathy
orphananesthesia Anesthesia recommendations for patients suffering from Welander distal myopathy Disease name: Welander distal myopathy ICD 10: G71.0 Synonyms: late adult onset type 1 distal myopathy;
More informationMedical Immunology Practice Questions-2016 Autoimmunity + Case Studies
Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies Directions: Each of the numbered items or incomplete statements in this section is followed by answers or by completions of the statement.
More informationHereditary quadriceps myopathy
Journal of Neurology, Neurosurgery, and Psychiatry, 1973, 36, 1041-1045 Hereditary quadriceps myopathy MICHAEL L. E. ESPIR AND W. B. MATTHEWS' From the Department of Neurology, Derbyshire Royal Infirmary,
More informationThe Major Histocompatibility Complex (MHC)
The Major Histocompatibility Complex (MHC) An introduction to adaptive immune system before we discuss MHC B cells The main cells of adaptive immune system are: -B cells -T cells B cells: Recognize antigens
More informationMyositis 101. Steven R. Ytterberg, M.D. Division of Rheumatology Mayo Clinic, Rochester, MN
Myositis 101 Steven R. Ytterberg, M.D. Rheumatology Mayo Clinic, Rochester, MN Myositis Association Annual Conference Louisville, KY Sept. 6 & 7, 2018 Disclosures Consulting: Dynavax Pfizer Off-label use:
More informationDMD Genetics: complicated, complex and critical to understand
DMD Genetics: complicated, complex and critical to understand Stanley Nelson, MD Professor of Human Genetics, Pathology and Laboratory Medicine, and Psychiatry Co Director, Center for Duchenne Muscular
More informationSignificance of antibody testing in idiopathic inflammatory myopathies
2/0/20 Significance of antibody testing in idiopathic inflammatory myopathies Jiří Vencovský Institute of Rheumatology, Prague Diagnosis Polymyositis Juvenile DM (JPM) Paraneoplastic Myositis in overlap
More informationPrinciples of Adaptive Immunity
Principles of Adaptive Immunity Chapter 3 Parham Hans de Haard 17 th of May 2010 Agenda Recognition molecules of adaptive immune system Features adaptive immune system Immunoglobulins and T-cell receptors
More informationLYMPH GLAND. By : Group 1
LYMPH GLAND By : Group 1 ANATOMY LYMPH NODE Lymphatic Organs Red bone marrow Thymus gland Lymph nodes Lymph nodules Spleen Primary organs Secondary organs Lymph Nodes Firm, smooth-surfaced, bean-shaped
More informationTitle. CitationNeurology and Clinical Neuroscience, 5(1): Issue Date Doc URL. Rights. Type. Additional There Information
Title Pseudodystonia in sarcoid myopathy Uwatoko, Hisashi; Yabe, Ichiro; Shirai, Shinichi; Ta Author(s) Hidenao CitationNeurology and Clinical Neuroscience, 5(1): 34-35 Issue Date 2017-01 Doc URL http://hdl.handle.net/2115/68037
More information1. Overview of Adaptive Immunity
Chapter 17A: Adaptive Immunity Part I 1. Overview of Adaptive Immunity 2. T and B Cell Production 3. Antigens & Antigen Presentation 4. Helper T cells 1. Overview of Adaptive Immunity The Nature of Adaptive
More informationMass Histology Service
Mass Histology Service A complete anatomical pathology laboratory www.masshistology.com Telephone: (877) 286-6004 Report on Pathology A Time Course Study of the Local Effects of Intramuscular XXXXXXX Injection
More informationChapter 35 Active Reading Guide The Immune System
Name: AP Biology Mr. Croft Chapter 35 Active Reading Guide The Immune System Section 1 Phagocytosis plays an important role in the immune systems of both invertebrates and vertebrates. Review the process
More informationChapter 13 Lymphatic and Immune Systems
The Chapter 13 Lymphatic and Immune Systems 1 The Lymphatic Vessels Lymphoid Organs Three functions contribute to homeostasis 1. Return excess tissue fluid to the bloodstream 2. Help defend the body against
More informationGenetics in inclusion body myositis
REVIEW C URRENT OPINION Genetics in inclusion body myositis Simon Rothwell a, James B. Lilleker a,b, and Janine A. Lamb c Purpose of review To review the advances in our understanding of the genetics of
More informationOverview of the Lymphoid System
Overview of the Lymphoid System The Lymphoid System Protects us against disease Lymphoid system cells respond to Environmental pathogens Toxins Abnormal body cells, such as cancers Overview of the Lymphoid
More informationCell Mediated Immunity (I) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:
Cell Mediated Immunity (I) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Learning Objectives By the end of this lecture you will be able to: 1 Understand
More informationvariant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still
157 Neurological disorders primarily affect and impair the functioning of the brain and/or neurological system. Structural, electrical or metabolic abnormalities in the brain or neurological system can
More informationInflammatory muscle diseases.
Thomas Jefferson University Jefferson Digital Commons Department of Neurology Faculty Papers Department of Neurology 4-30-2015 Inflammatory muscle diseases. Marinos C Dalakas Department of Neurology, Neuromuscular
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/35124 holds various files of this Leiden University dissertation. Author: Wokke, Beatrijs Henriette Aleid Title: Muscle MRI in Duchenne and Becker muscular
More informationIDIOPATHIC INFLAMMATORY MYOPATHIES AND RELATED DISORDERS. Franclo Henning Division of Neurology Tygerberg Hospital
IDIOPATHIC INFLAMMATORY MYOPATHIES AND RELATED DISORDERS Franclo Henning Division of Neurology Tygerberg Hospital Classification systems Clinical (Bohan and Peter) Clinico-pathological (Dalakas & others)
More informationPathology of Neuromuscular Disease Part 1: muscle
Pathology of Neuromuscular Disease Part 1: muscle Zarife Sahenk, MD. PhD. Research Institute at Nationwide Children s Hospital Center for gene therapy, Neuromuscular Program Experimental & Clinical Neuromuscular
More informationAutoimmune Diseases. Betsy Kirchner CNP The Cleveland Clinic
Autoimmune Diseases Betsy Kirchner CNP The Cleveland Clinic Disclosures (financial) No relevant disclosures Learning Objectives Explain the pathophysiology of autoimmune disease Discuss safe administration
More informationAntigen Presentation to T lymphocytes
Antigen Presentation to T lymphocytes Immunology 441 Lectures 6 & 7 Chapter 6 October 10 & 12, 2016 Jessica Hamerman jhamerman@benaroyaresearch.org Office hours by arrangement Antibodies and T cell receptors
More informationTreatment of sporadic inclusion body myositis with bimagrumab
Treatment of sporadic inclusion body myositis with bimagrumab Anthony A. Amato, MD Kumaraswamy Sivakumar, MD Namita Goyal, MD William S. David, MD, PhD Mohammad Salajegheh, MD Jens Praestgaard, PhD Estelle
More informationUNICORNS, DRAGONS, POLYMYOSITIS AND OTHER MYTHOLOGICAL BEASTS: THE TRUTH ABOUT POLYMYOSITIS
UNICORNS, DRAGONS, POLYMYOSITIS AND OTHER MYTHOLOGICAL BEASTS: THE TRUTH ABOUT POLYMYOSITIS Tahseen Mozaffar, MD University of California, Irvine Polymyositis is a commonly diagnosed condition in Neurology,
More informationPOLYMYOSITIS (PM) DERMATOMYOSITIS (DM) Body myositis Eosinophilic myositis Giant cell myositis Focal / localised myositis Myopathies caused by
POLYMYOSITIS (PM) DERMATOMYOSITIS (DM) Body myositis Eosinophilic myositis Giant cell myositis Focal / localised myositis Myopathies caused by infections, drugs, toxins Definition Epidemiology Pathogenesis
More informationMyosites du sujet âgé
Myosites du sujet âgé Olivier Benveniste Département de Médecine Interne Centre de Référence Maladies Neuro-Musculaires Equipe Muscle Inflammatoire U974 Groupe Hospitalier Pitié-Salpêtrière Myositis classification
More informationBachelor of Chinese Medicine ( ) AUTOIMMUNE DISEASES
Bachelor of Chinese Medicine (2002 2003) BCM II Dr. EYT Chan February 6, 2003 9:30 am 1:00 pm Rm 134 UPB AUTOIMMUNE DISEASES 1. Introduction Diseases may be the consequence of an aberrant immune response,
More informationNormal thyroid tissue
Thyroid Pathology Overview Normal thyroid tissue Normal thyroid tissue with follicles filled with colloid. Thyroid cells form follicles, spheres of epithelial cells (always single layered in health, usually
More informationGeneration of the Immune Response
Generation of the Immune Response Sheet 18 immunity I only added extra notes that were explained in the lecture, refer back to the slides. SLIDE 3: In the generation of Immune response whether by B or
More informationHLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol
HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared
More informationThird line of Defense
Chapter 15 Specific Immunity and Immunization Topics -3 rd of Defense - B cells - T cells - Specific Immunities Third line of Defense Specific immunity is a complex interaction of immune cells (leukocytes)
More informationImmunotherapy of myositis: issues, concerns and future prospects
Immunotherapy of myositis: issues, concerns and future prospects Marinos C. Dalakas abstract The main inflammatory myopathies within the myositis group include polymyositis, dermatomyositis and inclusion
More informationCURRENT ESSENTIALS IN INFLAMMATORY MYOPATHIES
CURRENT ESSENTIALS IN INFLAMMATORY MYOPATHIES Maren Breithaupt, 1 Jens Schmidt 1,2 1. Clinic for Neurology, University Medical Center Göttingen, Göttingen, Germany 2. Department of Neuroimmunology, Institute
More informationInflammatory Myopathies 4 th year MBBS. Marwan Adwan MBChB, MSc, MRCPI, MRCP(rheum) Consultant Rheumatologist
Inflammatory Myopathies 4 th year MBBS Marwan Adwan MBChB, MSc, MRCPI, MRCP(rheum) Consultant Rheumatologist Case A 64 woman presents with erythematous itchy rash over back of hands & forehead. For 1 month
More informationCOURSE: Medical Microbiology, MBIM 650/720 - Fall TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12
COURSE: Medical Microbiology, MBIM 650/720 - Fall 2008 TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12 FACULTY: Dr. Mayer Office: Bldg. #1, Rm B32 Phone: 733-3281 Email: MAYER@MED.SC.EDU
More informationBlood and Immune system Acquired Immunity
Blood and Immune system Acquired Immunity Immunity Acquired (Adaptive) Immunity Defensive mechanisms include : 1) Innate immunity (Natural or Non specific) 2) Acquired immunity (Adaptive or Specific) Cell-mediated
More informationThe Adaptive Immune Response. T-cells
The Adaptive Immune Response T-cells T Lymphocytes T lymphocytes develop from precursors in the thymus. Mature T cells are found in the blood, where they constitute 60% to 70% of lymphocytes, and in T-cell
More informationMyopathy with anti-jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres
472 Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA T MozaVar A Pestronk Correspondence to: Dr Alan Pestronk, Department of Neurology, Box 8111, 660 South Euclid
More information